396 related articles for article (PubMed ID: 31871543)
61. Genetic absence of ALOX5 protects from homocysteine-induced memory impairment, tau phosphorylation and synaptic pathology.
Li JG; Barrero C; Merali S; Praticò D
Hum Mol Genet; 2017 May; 26(10):1855-1862. PubMed ID: 28334897
[TBL] [Abstract][Full Text] [Related]
62. [Relationship between Polymorphism in ALOX5, ALOX5AP and Susceptibility to Myeloid Leukemia].
Mei F; Wang YF; Yang D; Zuo RX; Shen T; Yang TH; Sa YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):40-50. PubMed ID: 32027251
[TBL] [Abstract][Full Text] [Related]
63. 5-lipoxygenase and FLAP.
Peters-Golden M; Brock TG
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
[TBL] [Abstract][Full Text] [Related]
64. Glucocorticoids sensitize rat placental inflammatory responses via inhibiting lipoxin A4 biosynthesis.
Zhang D; Li Y; Peng H; Liu H; Cheng Q; Cheng X; Zeng P; Wu P; Chen H; Huang Y; Ye D
Biol Reprod; 2014 Apr; 90(4):74. PubMed ID: 24571985
[TBL] [Abstract][Full Text] [Related]
65. 5-lipoxygenase: regulation and possible involvement in atherosclerosis.
Rådmark O; Samuelsson B
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):162-74. PubMed ID: 17481551
[TBL] [Abstract][Full Text] [Related]
66. A functional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction.
González P; Reguero JR; Lozano I; Morís C; Coto E
Int J Immunogenet; 2007 Apr; 34(2):127-30. PubMed ID: 17373938
[TBL] [Abstract][Full Text] [Related]
67. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer.
Clària J; Romano M
Curr Pharm Des; 2005; 11(26):3431-47. PubMed ID: 16250846
[TBL] [Abstract][Full Text] [Related]
68. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
Manev H; Manev R
Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
[TBL] [Abstract][Full Text] [Related]
69. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
70. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.
Kanaoka Y; Austen KF
Adv Immunol; 2019; 142():65-84. PubMed ID: 31296303
[TBL] [Abstract][Full Text] [Related]
71. Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes.
Zhang C; Yu H; Ni X; Shen S; Das UN
PLoS One; 2015; 10(4):e0123256. PubMed ID: 25886460
[TBL] [Abstract][Full Text] [Related]
72. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness.
Kim SH; Bae JS; Suh CH; Nahm DH; Holloway JW; Park HS
Allergy; 2005 Jun; 60(6):760-5. PubMed ID: 15876305
[TBL] [Abstract][Full Text] [Related]
73. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice.
Qi J; Kim JW; Zhou Z; Lim CW; Kim B
Am J Pathol; 2020 Jan; 190(1):68-81. PubMed ID: 31610178
[TBL] [Abstract][Full Text] [Related]
74. Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase products.
Boudreau LH; Bertin J; Robichaud PP; Laflamme M; Ouellette RJ; Flamand N; Surette ME
FASEB J; 2011 Mar; 25(3):1097-105. PubMed ID: 21098726
[TBL] [Abstract][Full Text] [Related]
75. [Inhibitors of 5-lipoxygenase].
Gápovský M; Remko M
Ceska Slov Farm; 2002 Mar; 51(2):55-62. PubMed ID: 11928277
[TBL] [Abstract][Full Text] [Related]
76. The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease.
Alvarez V; González P; Corao AI; Menéndez M; Lahoz CH; Martínez C; Calatayud M; Morales B; Coto E
Alzheimer Dis Assoc Disord; 2008; 22(2):177-80. PubMed ID: 18525291
[TBL] [Abstract][Full Text] [Related]
77. Arachidonic acid cascade inhibitors modulate phorbol ester-induced oxidative stress in female ICR mouse skin: differential roles of 5-lipoxygenase and cyclooxygenase-2 in leukocyte infiltration and activation.
Nakamura Y; Kozuka M; Naniwa K; Takabayashi S; Torikai K; Hayashi R; Sato T; Ohigashi H; Osawa T
Free Radic Biol Med; 2003 Nov; 35(9):997-1007. PubMed ID: 14572603
[TBL] [Abstract][Full Text] [Related]
78. 5-lipoxygenase: cellular biology and molecular pharmacology.
Werz O
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):23-44. PubMed ID: 14561204
[TBL] [Abstract][Full Text] [Related]
79. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.
Antoine C; Murphy RC; Henson PM; Maclouf J
Biochim Biophys Acta; 1992 Oct; 1128(2-3):139-46. PubMed ID: 1329972
[TBL] [Abstract][Full Text] [Related]
80. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase.
Choi JH; Park HS; Oh HB; Lee JH; Suh YJ; Park CS; Shin HD
Hum Genet; 2004 Mar; 114(4):337-44. PubMed ID: 14749922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
